These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16329106)

  • 1. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
    Kruithof E; De Rycke L; Roth J; Mielants H; Van den Bosch F; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Dec; 52(12):3898-909. PubMed ID: 16329106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis.
    Kruithof E; De Rycke L; Vandooren B; De Keyser F; FitzGerald O; McInnes I; Tak PP; Bresnihan B; Veys EM; Baeten D;
    Arthritis Rheum; 2006 Jun; 54(6):1795-804. PubMed ID: 16729282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
    Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy.
    Kruithof E; Baeten D; Van den Bosch F; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Apr; 64(4):529-36. PubMed ID: 15388510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.
    Baeten D; Kruithof E; Van den Bosch F; Demetter P; Van Damme N; Cuvelier C; De Vos M; Mielants H; Veys EM; De Keyser F
    Arthritis Rheum; 2001 Jan; 44(1):186-95. PubMed ID: 11212159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
    Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy.
    Briot K; Roux C; Gossec L; Charni N; Kolta S; Dougados M; Garnero P
    J Rheumatol; 2008 Feb; 35(2):310-4. PubMed ID: 18203315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
    Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC
    J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks.
    Lisbona MP; Maymo J; Perich J; Almirall M; Pérez-García C; Carbonell J
    J Rheumatol; 2008 Mar; 35(3):394-7. PubMed ID: 18203329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial.
    Flagg SD; Meador R; Hsia E; Kitumnuaypong T; Schumacher HR
    Arthritis Rheum; 2005 Aug; 53(4):613-7. PubMed ID: 16082643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
    Delaunay C; Farrenq V; Marini-Portugal A; Cohen JD; Chevalier X; Claudepierre P
    J Rheumatol; 2005 Nov; 32(11):2183-5. PubMed ID: 16265699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry.
    Tilleman K; Van Beneden K; Dhondt A; Hoffman I; De Keyser F; Veys E; Elewaut D; Deforce D
    Proteomics; 2005 May; 5(8):2247-57. PubMed ID: 15846842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis.
    Kruithof E; Van den Bossche V; De Rycke L; Vandooren B; Joos R; Cañete JD; Tak PP; Boots AM; Veys EM; Baeten D
    Arthritis Rheum; 2006 Aug; 54(8):2594-604. PubMed ID: 16868982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis.
    Cui Y; Xiao Z; Shuxia W; Zhenjun Z; Hengguo Z; Liangyi F; Weicheng G; Li L; Guangfeng Z; Yunzhen S; Guangfu D
    Scand J Rheumatol; 2010 May; 39(3):229-32. PubMed ID: 20109079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.
    Baeten D; Demetter P; Cuvelier CA; Kruithof E; Van Damme N; De Vos M; Veys EM; De Keyser F
    J Pathol; 2002 Mar; 196(3):343-50. PubMed ID: 11857499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.